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Abstract
There is considerable evidence that influenza A virus (IAV) promotes adherence, colonization, and superinfection by S.
pneumoniae (Spn) and contributes to the pathogenesis of otitis media (OM). The complement system is a critical innate
immune defense against both pathogens. To assess the role of the complement system in the host defense and the
pathogenesis of acute pneumococcal OM following IAV infection, we employed a well-established transtympanically-
induced mouse model of acute pneumococcal OM. We found that antecedent IAV infection enhanced the severity of acute
pneumococcal OM. Mice deficient in complement C1qa (C1qa2/2) or factor B (Bf 2/2) exhibited delayed viral and bacterial
clearance from the middle ear and developed significant mucosal damage in the eustachian tube and middle ear. This
indicates that both the classical and alternative complement pathways are critical for the oto-immune defense against acute
pneumococcal OM following influenza infection. We also found that Spn increased complement activation following IAV
infection. This was characterized by sustained increased levels of anaphylatoxins C3a and C5a in serum and middle ear
lavage samples. In contrast, mice deficient in the complement C5a receptor (C5aR) demonstrated enhanced bacterial
clearance and reduced severity of OM. Our data support the concept that C5a-C5aR interactions play a significant role in the
pathogenesis of acute pneumococcal OM following IAV infection. It is possible that targeting the C5a-C5aR axis might prove
useful in attenuating acute pneumococcal OM in patients with influenza infection.
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Introduction
Otitis media (OM) is one of the most common diseases among
infants and young children worldwide. Children with OM are at
an increased risk of secondary bacterial infection following an
upper respiratory viral infection [1], [2], [3]. Epidemiological,
clinical, and experimental evidence have long supported an
association between antecedent influenza A viral (IAV) respiratory
tract infection and OM. IAV promotes Streptococcus pneumoniae
(Spn)-induced OM [4], [5], [6], [7]. Multiple molecular mecha-
nisms have been implicated in IAV–Spn synergism [8], [9]. We
and others have reported that IAV enhances Spn nasopharyngeal
colonization, which is a prerequisite for the development of OM
[6], [7]. Viral compromise of eustachian tube (ET) mucosal
integrity results in impaired bacterial clearance and negative
pressure in the middle ear in the chinchilla OM model [10], [11],
[12]. Virus-modulated host immune and inflammatory responses
also play a significant role in pneumococcal OM [13], [14]. Two
recent reports suggest that mice pre-colonized with Spn are more
susceptible to IAV [14], [15]. They found that the inflammatory
response to IAV infection mediates pneumococcal replication in
the middle ear cavity in an infant mouse model of OM [14]. Much
more needs to be learned about the interactions between IAV and
Spn and their combined role in the host immune response, the
host defense, and the pathogenesis of OM.
The complement system is a major component of the host
innate immune defense system against infection [16]. Activation of
the complement system in response to invading pathogens is
mediated through the classical, alternative, and lectin pathways.
Activation results in C3 cleavage, release of anaphylatoxins C3a
and C5a, and the formation of a membrane attack complex (C5b-
9) that lyses target cells. Cleavage of C3 generates the key
opsonins, C3b and iC3b. These proteins tag the pathogens for
phagocytosis [16]. We previously reported that the complement
system is activated in the middle ear during acute pneumococcal
OM [17], [18]. Both the classical and alternative pathway
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activations were shown to play important roles in complement
mediated opsonophagocytosis of Spn in the middle ear of mice.
Other investigators have demonstrated that C3 is required for
protection from influenza infection, adequate viral clearance, and
inflammatory cellular infiltration [19].
The complement system has been described as a double-edged
sword because of its dual role in host defense and pathogenesis of
disease [16]. Generation of anaphylatoxins C3a, C4a, and C5a
that is not specific for invading pathogens can contribute to the
pathogenesis of various acute and chronic inflammatory diseases
[20]. A recent report shows that complement C5 activation during
Influenza A infection contributes to neutrophil recruitment and
lung Injury in mice [21]. Inhibition of C5 activation reduces
excessive inflammatory reactions associated with the severe forms
of IAV infections [21]. C5a also plays a significant role in both
inflammatory and immune effects through interactions with C5a
receptors, C5aR (CD88) and a second receptor, the C5a-like
receptor 2(C5L2). Expression of C5aR has been reported on many
cell types including several myeloid cells (e.g., neutrophils,
monocytes/macrophages, and mast cells) and non-myeloid cells
such as epithelial and endothelial cells [22]. Interaction of C5a/
C5aR leads to the induction of local inflammation through cellular
degranulation, increased vascular permeability, and leukocyte
recruitment to the site of injury or infection [22]. However, much
less is known about the role and extent of complement activation
during acute pneumococcal OM following IAV infection.
In the current study, we utilized a well-established transtympa-
nically-induced acute pneumococcal OM mouse model following
an IAV infection to investigate how complement activation in this
setting affects the middle ear defense against acute pneumococcal
OM. The studies were conducted in four groups of mice that
differed in their ability to activate various components of
complement. Mice deficient in C1qa (C1qa 2/2) are unable to
activate complement through the classical pathway. Mice deficient
in factor B (Bf 2/2) are unable to activate complement through the
alternative pathway. Mice deficient in C5aR are unable to interact
with C5a. Parental wild-type (WT) mice served as controls. The
mice were inoculated intranasally with IAV and then challenged
transtympanically 7 days later with Spn type 6A. All cohorts were
observed over a 14-day period after inoculation with Spn. These
studies revealed that both the classical and alternative pathways
are critical components of the otological innate immune defense
against Spn following IAV infection. We were also able to show
that complement activation promoted increased production of
C5a. This was associated with more severe inflammation in Spn-
induced OM following IAV infection. In contrast, deficiency in
C5aR attenuated the generation of inflammatory mediators and
accelerated Spn clearance in this model.
Materials and Methods
Infectious agents
Spn type 6A (EF3114) with a predominant transparent
phenotype was provided by B. Anderson, Department of Clinical
Immunology, University of Go¨teborg, Sweden [23]. The growth
conditions and inocula were prepared as previously described [17].
Influenza virus strain A/Puerto Rico/8/34 H1N1 (A/PR/8/34)
was obtained from Charles River Laboratories Avian Vaccine
Services (North Franklin, CT). The HA titer of the purchased
virus was 1:65,536 per 0.05 ml, and the 50% embryo infectious
dose (EID50) titer was 109.5/ml.
Mice
Eight to 12-week-old male or female C57BL/6 mice were used
in this study. C57BL/6 mice homozygous for gene deficiencies of
C1qa (C1qa2/2) and factor B (Bf 2/2) were generated as
previously described [24], [25]. C1qa 2/2 and Bf 2/2 mice were
backcrossed at least 9 generations onto the C57BL/6 background.
Age and sex matched C57BL/6 (WT) mice, used as controls, were
obtained from the Jackson Laboratories (Bar Harbor, ME).
C5ar12/2 mice with genetic background of BALB/c, and
BALB/c (WT) mice were obtained from The Jackson Laboratory.
Blood samples from 3–5 mice with the same genetic background
were obtained by cardiac puncture. Single use aliquots of the sera
were stored at 270uC. All study procedures were approved by
The Institutional Animal Care and Use Committee at the Ohio
State University.
Mouse models of acute pneumococcal OM without prior
IAV Infection
Acute pneumococcal OM was induced by direct bilateral
transtympanical inoculation of the middle ear, as previously
described [26]. Briefly, mice were anesthetized by intraperitoneal
injection with ketamine hydrochloride (20 mg/kg of body weight)
and xylazine (5 mg/kg). Acute pneumococcal OM was then
produced by the inoculation of 5 ml of a suspension containing
approximately 500 CFU of Spn type 6A in sterile pyrogen-free
saline. A control cohort of five mice was sham inoculated with 5 ml
of diluent alone. On days 1, 3, 7, and 14 post Spn infection, mice
were anesthetized and then sacrificed. The middle ear spaces were
lavaged to quantitatively determine titers of Spn as previously
described [17]. Blood for serum samples was collected via cardiac
puncture and quantitatively cultured to determine bacterial
dissemination. The middle ear lavage and blood samples were
cultured overnight at 37uC on Columbia CNA agar plates in an
incubator supplemented with humidity and 5% CO2. The number
of CFU per milliliter was determined by a standard dilution assay
and plate counting.
Antecedent Influenza A virus infection
Mice were infected intranasally (i.n.) with a sublethal dose of
102.5 EID50 of A/PR8/34 influenza virus in 25 ml 7 days prior to
transtympanical inoculation with about 500 CFU of Spn type 6A.
This influenza dose was optimized to give ,10% weight loss in
WT mice during the peak of infection and allowed for recovery
without incidence of mortality. The viral titers (PFU/ml) in the
tracheonasal and middle ear lavage samples were determined by
plaque assay on Madin-Darby Canine Kidney (MDCK) cell
monolayers as previously published [27].
Histology
Six temporal bones from each cohort were removed immedi-
ately after sacrifice at 24, 48 and 72 h post Spn challenge. The
samples were processed for hematoxylin and eosin staining as
described previously [17].
Immunohistochemistry
Temporal bones from 3 mice in each cohort were removed
immediately after sacrifice at 24 h post-challenge. The samples
were processed as described previously with minor modifications
[18]. The middle ear sections were deparaffinized and rehydrated
through histoclear and graded alcohol series. The endogenous
peroxidase activity was blocked with 0.3% H2O2 in 0.1 M
phosphate-buffered saline (PBS) (pH 7.4) and the sections were
incubated with 0.05% trypsin solution (Invitrogen) at 37uC for
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20 min to unmask antigens. The sections were then blocked with
PBS (pH 7.2) containing 1% bovine serum albumin (BSA), 5%
donkey serum, and 0.3% Triton X-100 for 1 h. The sections were
then incubated at 4uC overnight with primary antibodies: goat-
anti mouse C5aR polyclonal antibody (1:200, Santa Cruz
Biotechnology, San Diego, CA), goat-anti mouse C3 (1:200, MP
Biomedicals, Solon, OH), or rabbit anti mouse C5b-9 (1:500,
abcam). Samples were washed and incubated with 1:500 dilutions
of secondary antibodies conjugated to DyLight 488 or DyLight
594 (Jackson ImmunoResearch Laboratories, West Grove, PA) at
room temperature for 1 h followed by incubation with DAPI
(1:10,000, Invitrogen) at room temperature for 2 minutes. The
sections were mounted with Vectashield Mounting Medium
(VectorLaboratories, Burlingame, CA). Immunostained samples
were examined with an Olympus Flowview 1000 laser scanning
confocal microscope.
Quantitation of complement and cytokine proteins in the
middle ear lavage and serum samples by ELISA
The middle ear lavage fluid samples from mice were centrifuged
at 5006g and the supernatants were aliquoted and frozen at 2
70uC. Concentrations of C3, C3a, C5a, CXCL1(KC), interleukin
6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1) were
determined using commercial ELISA kits (GenWay Biotech, San
Diego, CA; Quantikine; R&D Systems, Minneapolis, MN),
according to the manufacturer’s instructions.
Statistical analysis
Data are presented as the mean 6 the standard error of the
mean (S.E.M.) or standard deviation of the mean (S.D.) as
indicated. Data were analyzed using SigmaStat (SPSS Inc.,
Chicago, IL). One-way ANOVA and the Holm-Sidak or Dunn’s
methods were used for the statistical analysis and pair-wise
multiple comparisons. Mann-Whitney U test was used to compare
the differences in Spn concentrations in middle-ear lavage samples
Fig. 1. Spn type 6A titers in the middle ear lavage and blood samples. Survival of Spn type 6A in the middle ear of WT (A), C1qa2/2 (B), and
Bf2/2 (C) mice infected with Spn with or without a prior influenza virus infection and in the blood sample of mice infected with Spn and IAV(D). Each
data point represents the geometric mean of CFU of Spn (6 SEM) per milliliter of the middle ear lavage fluid and blood samples. All samples were
collected from a total of 6 to 8 animals combined from two separate experiments. Relative P values are indicated for each pairwise comparison. The
dashed line represents the detection limit of the assay.
doi:10.1371/journal.pone.0095160.g001
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of the cohorts inoculated with Spn alone against those inoculated
with Spn in combination with an antecedent influenza A virus
infection and the differences in bacterial and viral titers between
complement deficient and WT mice. Fisher exact test analysis was
used to examine the differences in frequency of positive blood
cultures Spn between complement deficient and WT mice infected
with Spn following IAV infection. In all cases, a P value of ,0.05
was set as the measure of significance.
Results
Antecedent IAV infection and complement deficiency
impaired Spn and viral clearance
Intranasal IAV followed seven days later by transtympanical
inoculation of Spn resulted in significantly higher bacterial titers
and delayed bacterial clearance from the middle ear compared to
Spn alone in WT, C1qa2/2, and Bf 2/2 mice (Fig. 1 A, B, C). On
day 1 post challenge, Spn concentrations in the middle ear lavage
samples from cohorts infected with both IAV and Spn were 1.0–
1.5 log10-fold higher than the groups infected with Spn alone (P,
0.05). On days 2 and 3 post challenge, the titers remained
significantly higher for cohorts infected with both IAV and Spn
than Spn alone (P,0.05). In the cohorts infected with Spn
following IAV infection, the titers of Spn type 6A in the middle ear
lavage samples of C1qa2/2 and Bf2/2 were significantly higher
than wild-type mice at 24 h (P=0.037 and P=0.007 respectively),
48 h (P=0.024 and P=0.005 respectively), and 72 h (P=0.034
and P=0.002 respectively) post infection. In addition, the
clearance kinetics for Spn were markedly different in WT and
complement deficient mice. The concentration of Spn 6A
remained detectable on day 7 post inoculation in cohorts infected
with both IAV and Spn in C1qa2/2 and Bf 2/2 mice. In contrast
Spn was eliminated from the middle ear in 7 out 8 WT mice
infected with both IAV and Spn (Fig. 1 A, B C).
Blood culture titers of Spn type 6A for each cohort coinfected
with IAV and Spn are shown in Fig. 1D. Persistent bacteremia was
noted for all the cohorts of the complement deficient mice across
the 24, 48, and 72 h time periods. Spn type 6A was isolated from
the blood samples of 54.5% of C1qa2/2, 43.5% of Bf 2/2, and
25% of wild-type mice during the 72 h observation period
(P=0.047 for C1qa2/2 versus wild-type mice). The frequency of
positive blood cultures was not significantly different between Bf
2/2 and C1qa2/2 mice. IAV titers in tracheonasal lavage samples
initially increased exponentially reaching maximum titers per ml
of lavage samples at 72 h post inoculation (Fig. 2A) for WT,
C1qa2/2, and Bf2/2 mice. However, viral titers remained high
through 10 days post infection in C1qa2/2, and Bf2/2 mice. Viral
titers in WT mice declined on days 7 and 10 as the mice began to
recover and the titers were significantly lower than C12/2qa or
Bf2/2 mice. IAV was cleared from the middle ear on day 7 in 9
out 10 WT mice. In contrast, IAV was detected in 7 out 10 C12/2
qa mice (P=0.020) and 6 out10 Bf2/2 mice (Fig. 2B).
Taken together, these data indicate that deficiencies in C1qa
and factor B tended to enhance the susceptibility to IAV and acute
pneumococcal OM following influenza.
Antecedent IAV infection and complement deficiencies
facilitated inflammation in the eustachian tube and
middle ear
Histopathological evaluation revealed that antecedent infection
with IAV enhanced eustachian tube and middle ear mucosal
inflammation during acute pneumococcal OM. Mock inoculation
did not induce structural changes in the ET and middle ear
mucosa. On day 3 post Spn inoculation, antecedent IAV infection
induced significant structural changes in the ET with fewer ciliated
cells and hyperplasia of mucosal epithelium with increased goblet
cells and inflammatory cells. C1qa or Bf deficient mice with
antecedent IAV infection showed increased ET damage (Fig. 3).
More inflammatory epithelium and mucosal thickening were
noted in the middle ear space of the antecedent IAV infected
cohorts than groups infected with either pathogen alone. The
changes in the middle ear mucosa were much more pronounced
and persistent in C1qa2/2 and Bf2/2 mice than in wild-type mice
(Fig. 4). These data demonstrate increased tissue damage and
inflammation in acute pneumococcal OM following influenza
virus infection, particularly in mice deficient in the classical or
alternative complement pathways.
Antecedent IAV infection induced enhanced
complement activation
We previously demonstrated that the complement alternative
pathway and C3 activation in the middle ear account for the local
immune response to Spn [18]. Influenza virus is known to induce
complement activation [28], [29]. Accordingly we were interested
in determining the effect of antecedent IAV infection on the extent
of activation of the complement system. We found that the levels
of anaphylatoxins C3a and C5a in the middle ear lavage fluid and
serum samples of cohorts infected with both IAV and Spn were
significantly higher than for mice infected with either pathogen
alone (Fig. 5A and 5B). Immunofluorescence staining for the
complement component deposition on the middle ear epithelium
on day 1 post Spn infection showed increased C3, C5aR (Fig. 6A),
and C5b-9 (Fig. 6B) deposition on the inflammatory middle ear
epithelium in the cohorts infected with both IAV and Spn
compared to those infected with either pathogen alone. These
findings indicate that prior IAV infection enhances complement
activation during acute pneumococcal OM.
Deficiency in C5aR reduced severity of acute
pneumococcal OM with an antecedent of influenza virus
infection
To further assess the functional role of the anaphylatoxin C5a in
the pathogenesis of acute pneumococcal OM, we investigated its
effect on the severity of OM in mice deficient in C5a receptor
(C5ar12/2). We first examined whether the complement activation
is comparable between
C5ar12/2 and its WT control mice during IAV infection or
acute pneumococcal OM with or without prior IAV infection.
Although the levels of anaphylatoxins C3, C3a, and C5a in the
middle ear lavage fluid samples of cohorts infected with both IAV
and Spn were significantly higher than for mice infected with
either pathogen alone in both C5ar12/2 and WT mice, there were
no significant differences in the levels of C3, C3a and C5a in the
middle ear lavage fluid samples of the infected cohorts between
C5ar12/2 and WT mice (Fig. 7). These data indicate that the
genetic manipulation in C5ar12/2 mice does not affect the
complement activation.
We found significantly more inflammatory cells in the lavage
samples collected from WT cohorts infected with both IAV and
Spn type 6A than C5ar12/2 mice at 24, 48, and 72 h post Spn
challenge (P,0.05) (Fig. 8A). There were more inflammatory cells
in the middle ear at 48 and 72 h post Spn infection in mice
infected with Spn alone (Fig 8A). Histopathological evaluation
showed that at 24 h post inoculation, more inflammatory cells and
mucosal thickening were noted in the middle ear space of WT
cohorts infected with both IAV and Spn compared to C5ar12/2
mice (Fig 8B, 8C). Bacterial titers of Spn in the middle ear lavage
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fluid samples from C5ar12/2 cohorts infected with both IAV and
Spn were significantly lower than in samples from WT mice at 24,
48, and 72 h post Spn infection (P,0.05) (Fig 8D). We found no
difference in Spn titers between Spn alone infected C5ar12/2 and
WT mice at 24 h post infection. However, Spn were eliminated
from the middle ear in 4 out of 10 C5ar12/2 mice at 48 h post
challenge, but in none of the WT mice.
In order to determine whether reduced inflammatory mediator
levels in C5ar12/2 mice infected with IAV and Spn might affect its
disease course of secondary acute pneumococcal OM, we
measured IL-6, MCP-1, and CXCL1/KC chemokine levels in
the middle ear lavage samples obtained at 24, 48, and 72 h post
Spn inoculation from mice infected with or without prior IAV
infection or with IAV alone. The levels of IL-6 and KC were
significantly higher in WT than in C5ar12/2 mice infected with
IAV alone on Day 8 post viral infection (Fig. 9). IL-6, MCP-1, and
KC levels were significantly higher in WT mice than in C5ar12/2
mice infected with both pathogens (P,0.01) (Fig. 9). Similarly, IL-
6 levels were significantly higher in WT mice than in C5ar12/2
mice infected with Spn alone (P,0.05 respectively).There were no
significant differences in the levels of CXCL1/KC among wild-
type and C5ar12/2 mice at 24 h infected with Spn alone, but there
were significant differences at 48 and 72 h post infection. These
data are consistent with greater influx of inflammatory cells in the
Fig. 2. Viral titers in tracheonasal and middle ear lavage samples. Viral clearance from the nasopharynx of WT, C1qa2/2, and Bf2/2 mice (A)
and viral titers on day 7 in middle ear (B). Each data point represents the geometric mean of PFU of IAV (6 SEM) per milliliter of the tracheonasal and
middle ear lavage fluid. All samples were collected from a total of 10 animals combined from two separate experiments. Relative P values are
indicated for each comparison with WT mice. The dashed line represents the detection limit of the assay.
doi:10.1371/journal.pone.0095160.g002
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middle ears of WT compared to C5ar12/2 mice. These findings
suggest that absence of the C5a-C5aR axis interactions results in
an increased bacterial clearance with a decreased inflammatory
response and pathology during acute pneumococcal OM following
influenza infection.
Discussion
Reports from our laboratory and others suggest that IAV
promotes Spn-induced OM [4], [5], [6], [7]. Clinically, IAV,
which infects primarily upper respiratory tract epithelial cells, is
closely associated with OM in children, especially those who are
Fig. 3. Representative H&E-stained sections of mid-portion of eustachian tube (ET). The structural changes on day 3 after Spn infection in
WT, C1qa2/2, and Bf 2/2 mice infected with influenza virus or either pathogen alone. The tissue damages of ETs in complement deficient mice
infected with IAV and Spn were evident (magnification,6200). Eustachian tube lumen is labeled with ‘‘L’’. Open arrowheads indicate ciliated mucosa.
Filled arrowheads indicate epithelial denudation in IAV infected cohorts, and thickened mucosal epithelium with goblet cell hyperplasia in Spn and
coinfected cohorts.
doi:10.1371/journal.pone.0095160.g003
Fig. 4. Representative H&E-stained middle ear sections.Middle ear inflammation on day 3 after Spn infection in WT, C1qa2/2, and Bf 2/2mice
infected with IAV or either pathogen alone. The enhanced inflammatory infiltrates and mucosa thickness in the middle ear epithelium were evident in
C1qa2/2 and Bf 2/2 mice infected with IAV and Spn. Open arrowheads indicate inflammatory cell infiltrates, and arrows indicate the middle ear
mucosa (magnification,6200).
doi:10.1371/journal.pone.0095160.g004
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carriers of Spn at the time of influenza virus infection [5]. Previous
studies of the mechanisms underlying the synergistic interaction
between Spn and influenza A virus have focused primarily on the
role of viral compromising the eustachian tube, mucosal integrity,
and tubal function in the chinchilla OM model. Although the
chinchilla OM model has been used for the study of antecedent
virus-bacterial infections because it resembles the natural route of
infection in humans, the lack of chinchilla strains with targeted
Fig. 5. Complement activation during OM. Concentrations of C3, C3a, and C5a in the middle ear lavage fluid samples (A) and serum samples (B)
from WT mice infected with a combination of IAV and Spn or either pathogen alone. Results are the mean concentrations (6 SEM) in the middle ear
lavage and serum samples from 5 mice from two separate experiments. *P,0.05 for the comparison of the combined infection with each single
pathogen alone. #, P,0.05 for the comparison of mice infected with Spn alone with IAV alone.
doi:10.1371/journal.pone.0095160.g005
Fig. 6. Representative immunofluorescence staining for complement component deposition in the middle ear mucosa. (A) C3 (green)
and C5aR (red) deposition in the middle ear mucosa at 24 h post Spn infection. Nucleic acids were stained with DAPI (blue). Faint staining was
observed in sham control mice. Increased C3 and C5aR immunofluorescence staining in the middle ear epithelium of mice infected with IAV and Spn
was evident. (B). Increased C5b-9 immunofluorescence staining (green) in the middle ear epithelium in mice at 24 after transtympanical inoculation
with Spn with a prior IAV infection compared with the sham control and single pathogen infected cohorts. Arrows indicate the middle ear mucosa.
Representative imagines from three mice are shown.
doi:10.1371/journal.pone.0095160.g006
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gene disruption and specific immunological reagents limits our
ability to use the model to dissect the contribution of important
components of the host’s immune response to the pathogens. The
mouse is a useful animal model for induction of middle ear
infection. The method of choice for OM induction, intranasal (i.n.)
or direct middle ear administration of pathogens, depends on the
experimental needs of the investigation. Induction of OM using an
i.n. challenge model is preferred for studies that involve evaluating
protective immunity against nasopharyngeal colonization and
subsequent infection in the middle ear. Direct middle ear
challenge provides the most direct approach to evaluating the
role of protective immunity against middle ear infection or
resolution of OM [30]. In the current dual infection model, we
used sublethal doses of both pathogens since the majority of
pediatric patients with OM do not have fatal infections. We
demonstrated that following IAV infection, Spn produced
significant structural changes in the ET and middle ear mucosa,
increased complement activation, higher titers of Spn, and
inflammatory mediators in the middle ear compared to Spn
alone. Thus our model can be used to elucidate the synergistic
molecular mechanisms during post-influenza acute pneumococcal
OM.
We previously reported that C3 activation and opsonophago-
cytosis of Spn were greatly attenuated in C1qa and factor B
deficient mice, which contributes to the enhanced susceptibility of
these mice to acute pneumococcal OM [17], [18]. In the current
study we were able to show that C1qa and factor B of the
complement components play an essential role in viral and Spn
clearance during acute pneumococcal OM following IAV
infection. One of the interesting findings in this study was that
following IAV infection C1qa and Bf deficient mice not only had
high levels of Spn in the middle ear, but also developed ET
structural damage with a delayed IAV clearance from the
nasopharynx and middle ear that could further facilitate the
severity of OM. It has been reported that the complement classical
pathway components C1, C3 and C4 are required for neutrali-
zation of influenza virus [31], [32], but as of yet the role of the
alternative pathway in this process is not clear. In the current
study, we demonstrated that factor B also plays a protective role at
least equal to C1qa in the middle ear defense against Spn during
IAV infection. Factor B is one of the components of the alternative
pathway and can be activated by microbial fragments. Spontane-
ously hydrolyzed C3 complexes with factor B and then is cleaved
by factor D to generate C3bBb, the alternative pathway C3
convertase that cleaves C3 to C3b. In addition, factor B amplifies
complement activation initiated through the classical/lectin
pathways. Multiple mechanisms appear to be responsible for
the enhanced susceptibility of C1qa and Bf deficient mice,
following IAV infection. Further studies are needed to understand
the mechanisms whereby influenza A virus enhances susceptibility
and the pathogenesis of pneumococcal OM.
OM is characterized by inflammation of the middle ear with the
predominance of polymorphonuclear neutrophil (PMN) in the
early stage, and lymphocytes and other mononuclear cells in the
late stage of OM along with the release of numerous proin-
flammatory cytokines and chemokines [33], [34], [35], [36].
Inflammation resolution during OM requires not only eradication
of bacteria or viruses by innate and adaptive immune mechanisms
but also a tight regulation of the inflammatory responses in the
middle ear space. Loss of control and consequent exaggeration
and prolongation of the inflammatory response can lead to tissue
injury in the middle ear cleft. In the present study, we showed that
antecedent IAV infection induced enhanced complement activa-
tion in the middle ear and serum in Spn infected mice. This was
demonstrated by the increased levels of C3, C3a, and C5a.
Immunostaining for C3, C5aR, and C5b-9 showed intense
deposition in the middle ear epithelium in mice during IAV
infection. Complement components including C3a, C5a, and
sC5b-9 have been detected in middle ear fluid and mucosa in both
clinical and experimental infections [37], [38]. Intense comple-
ment activation has been demonstrated in chronic otitis media
with effusion (OME) in association with persistent inflammation in
the middle ear [39]. We recently reported that levels of C3a, C5a,
and sC5b-9 in the middle ear are informative biomarkers for
persistent inflammation during recurrent acute OM in children
[40]. It is well known that C5a binding to C5aR or C5L2 exerts a
range of biological effects including the chemoattraction of
inflammatory cells and induction of the ‘‘cytokine storm’’ during
the inflammatory response [41]. The effects elicited by C5a/C5aR
interaction appear to be organ and cell-type-specific [42].
In the current study, we use C5ar12/2 mice to determine the
functional role of these interactions in the development of
secondary acute pneumococcal OM following influenza infection.
We observed that levels of IL-6, mKC, and MCP-1 were
substantially reduced, along with reduced inflammatory cell
recruitment, mucosal inflammation and improved bacterial
clearance in the middle ear of C5ar12/2 mice. We think that
the deletion of C5aR contributes to the reduced proinflammatory
immune responses resulting in increased Spn clearance and
augmented resolution of inflammation in response to Spn and IAV
Fig. 7. Deletion of C5aR did not affect the complement activation during acute pneumococcal OM. Concentrations of C3, C3a, and C5a
in the middle ear lavage samples on days 1, 3, and 7 post Spn infection (corresponding to days 8, 9 and 10 post-viral infection) in WT and C5ar12/2
mice infected with Spn alone, or Spn with prior IAV, or IAV alone. Results are the mean concentrations (6 SEM) in the middle ear lavage pooled from
five mice from two separate experiments. There were no significant differences in the concentrations of C3, C3a and C5a between C5ar12/2 and WT
mice.
doi:10.1371/journal.pone.0095160.g007
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in our model. In this regard, Short et al. demonstrated that the
enhanced inflammatory response induced by IAV facilitates
pneumococcal growth and subsequent episodes of acute OM
[14]. Others suggested that an immunopathologic response such as
inflammation-mediated epithelial denudation or a viral preoccu-
pation of the innate immune system may provide a more
hospitable environment for pneumococcal outgrowth and disease
in influenza virus-pneumococcus synergy [43]. Further investiga-
tions are required to understand the specific inflammatory
components responsible for increased bacterial replication and
disease [43].
In the current study we focused on C5aR without specifically
investigating the role of C5L2. C5L2 has been shown to play a
proinflammatory role during sepsis through intracellular signaling,
release of cytokines IL-6, tumor necrosis factor a (TNF-a), and
high mobility group box 1(HMGB1) [44]. C5L2 also plays an anti-
inflammatory role as a recycling decoy receptor or via b-arrestin
pathway [44]. In this study, although the level of IL-6 in the
middle ear was statistically lower in C5ar12/2 than WT mice, the
high level of IL-6 on day 1 post Spn infection in the coinfection
cohort might be attributed to the modulation of C5L2. The
expression and function of C5L2 warrant further investigation,
Fig. 8. Deficiency in C5aR enhances bacterial clearance and reduces the severity of acute pneumococcal OM. (A). Accumulation of
inflammatory cells in the middle ears of mice following transtympanical inoculation of Spn. Each data point represents the mean concentration of
inflammatory cells (6 SEM) per cubic millimeter of the middle ear lavage fluid. These results were obtained from a total of 6 to 11 animals combined
from two separate experiments. *, P,0.05 for the comparison of the WT with C5ar12/2 mice infected with IAV and Spn or WT mice infected with Spn
alone. #. P,0.05 for the comparison of the C5ar12/2 mice infection with both pathogens with Spn alone infected C5ar12/2 mice. +. P,0.05 for the
comparison of C5ar12/2 mice infected with Spn alone iwith WT mice. (B) and (C). Representative H&E-stained middle ear sections of the mice at 24 h
post Spn infection from coinfected WT (B) and C5ar12/2 mice (C). Arrows indicate the middle ear mucosa. (D) Survival of Spn type 6A in the middle
ear of WT and C5ar12/2 mice coinfected with influenza virus or mice infected with Spn alone. Each data point represents the mean of CFU of Spn (6
SEM) per milliliter of the middle ear lavage fluid samples from a total of 6 to 8 animals combined from two separate experiments. Relative P values are
indicated for each pairwise comparison. The dashed line represents the detection limit of the assay.
doi:10.1371/journal.pone.0095160.g008
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especially the possible attenuation or propagation of inflammation
during acute pneumococcal OM.
To the best of our knowledge, the current report is the first to
present the role of C5a/C5aR interactions in acute pneumococcal
OM pathogenesis. Our data are consistent with a previous study
showing that a C5 deficiency and C5a blockade protects mice
against pneumococcal meningitis [45]. Therapeutic interventions
using neutralizing antibodies against C5a or C5aR and C5aR
antagonists remain attractive targets for human disease models
such as sepsis, cancer, inflammatory bowel disease, arthritis, and
pregnancy-related complications [46], [47]. Our findings suggest
that the targeting of the C5a and C5aR axis may have therapeutic
potential for OM and that this targeting warrants further
investigation.
In conclusion, our data indicate that deficiencies in the
complement classical and alternative pathways contribute to
enhanced susceptibility to acute pneumococcal OM following
infection with IAV. The complement component C5a in the
middle ear induced following IAV infection and Spn facilitates the
severity of acute pneumococcal OM. Using C5aR deficient mice
we demonstrated that the middle ear inflammatory responses were
attenuated during acute pneumococcal OM with prior IAV
infection. These findings suggest that pharmacological targeting of
the C5a-C5aR axis might attenuate the progression of acute
pneumococcal OM following influenza virus infection.
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